HEB Archives - Page 3 of 6 - Blue Horseshoe Stocks

Blue Horseshoe Stocks: Friday Recap, DRL & More

Reviewing Friday’s Top Picks

iBio, Inc. IBIO

The number one mover from our Friday morning report was undoubtedly IBIO. Our recent observation that increasing concerns over the presence of the Ebola virus on American soil would drive related stocks paid off in spades.

IBIO was among those to get a huge boost on unconfirmed reports that it would aid in government efforts to speed production of the ZMapp experimental Ebola treatment.

The stock would see a low of .89 near the beginning of the session, and ended up running extremely hard into the close, reaching a high of 1.57. That equals out to an intraday surge of 76% but our total possible gains didn’t stop there. The stock continues to roll this morning, having hit a high of 2.76 in the premarket and pushing the total amount of the increase we’ve seen on IBIO since Friday morning to an impressive 210%

Alpha Pro Tech Ltd. APT

Like IBIO, APT was also affected by Ebola fears on Friday, and traded in a less extreme but similar pattern. After seeing a morning low of 5.72, the stock pushed the envelope into the close, reaching a peak of 7.43 for a 30% intraday gain. It is also gapping up bigtime today, with a premarket high of 9.25, which marks a 62% move up from Friday morning’s low.

Doral Financial Corp. DRL

Some of our more seasoned subscribers will certainly remember our coverage of DRL this year. We were waiting to get word on the company’s tax suit against the Puerto Rican governement, and Friday following market close, it was announced that the court has ruled in favor of Doral, which will be due the disputed-over sum of $229M.

As a result of this untraded-upon news, the stock is gapping up like crazy today, to the tune of a 9.46 premarket high, up well over 100% above the low we observed following our initial alert on DRL this summer.

We’ll probably see some selling pressure from profit taking in a situation like this, so we’ll be on the lookout for a potential dip-and-rip scenario to kick off the week.

Extended Watchlist:
AHPI, HEB, NSPH, SMED, FOMX, OBCI,

Blue Horseshoe Stocks: Bottom Play Alert, HEB & More

FBC Holdings, Inc. FBCD

We wanted send out an alert on FBCD this morning, if for no other reason than the fact that it’s been quite awhile since we found a bottom play trading near all-time lows in the super-subpenny range. We’ve definitely been known to do some bottom-fishing in our day, with some of our biggest wins coming from bargain shopping.

What we have in FBCD is a stock that has been beaten back to a record low of .0005 (reached yesterday) which catches our attention in a big way. We are going to stay vigilant as we monitor this play for a solid bottom, because a snapback to to the double-zero range is not only very possible, but also has the potential to happen quite rapidly.

With so little room to the downside, one might classify FBCD as a “lottery ticket” type of play. The action on super-subpennies have the potential to return exponential gains, which is why we’re going to give it a spot on our running watchlist.

A quick glance at the chart shows that each time an influx of volume has come into the stock, it makes a run to test its 50DMA. From present levels, a jump to the current 50DMA would mean a chance for gains of at least 66%

Hemishperx BioPharma, Inc. HEB

We were passively tracking HEB via our extended watchlist last month, and are going to keep giving it our attention as the new quarter kicks off today. The stock is gapping up to the tune of roughly 25% in the premarket.

We caught notice of HEB following the company’s announcement that it would collaborate with US Army Medical Research to develop treatments to attempt to overcome the emergence of drug resistance due to Ebola virus mutation.

With the current Ebola breakout making it a hot-button topic, and the company stating this week that it would be expanding its Ebola research, we’re going to still be keeping our ears to the ground on this one.

Spherix, Inc. SPEX

SPEX made an appearance in yesterday morning’s extended watchlist and had one heck of a solid session. The stock came out of the gate and ran from a low of .99 all the way up to 1.58, offering us the chance to bank up to 60% in profits as it traded more than 13.5X its 3-month average volume.

Disappointment over the delay of some upcoming litigation that Shperix has against VTech and Uniden (View PR) is the apparent cause of the stock’s gapping down in today’s premarket.

Extended Watchlist:
LAKE, BCRX, ANGI, RVP, NNVC, CGA

Blue Horseshoe Stocks: TRTC, RPRX Recaps & MKHD

Mount Knowledge Holdings, Inc. MKHD

MKHD is one that we want to flag this morning after our news scanner picked up an intriguing PR that just hit the wires. Apparently the company has moved to acquire cyber-security firm Civergy, Inc, which apparently generated revenue in excess of $35M last year.

It’s going to be interesting to see how this stock, which is unaccustomed to heavy trading, responds to this significant development.

NEW YORK, NY–(Marketwired – September 29, 2014) – Mount Knowledge Holdings, Inc. (MKHD), a software development and sales company focused on providing innovative technology solutions announced today that it has entered into a definitive agreement to acquire 100% of Civergy, Inc, >>> VIEW PR

Terra Tech Corp. TRTC

Among the cannabis plays that we were watching for a resurgence on Friday was TRTC, which put forth a significantly fruitful session as the stock came out of the gate at .25 and ran up as high as .33 on volume exceeding twice the 3-month average.

That move was good for intraday gains of up to 32% and marked the fourth consecutive day that TRTC registered both higher lows and higher highs. It leaves the stock firmly near the top of our marijuana watchlist which is certain to garner more attention as we approach voting season.

Repros Therapeutics, Inc. RPRX

We also saw a nice pop out of RPRX, which appeared in Friday’s extended watchlist, and would go on to post a solid performance on the day. After trading as low as 9.23, we witnessed a run to 11.18, a bullish move of 21% on just a shade under four times its 3-month average volume.

It’s a good signal that after the recent beatdown of the stock from the $14+ range that we’re seeing a turnaround, so we’ll definitely have RPRX on our radar going forward.

Extended Watchlist:
ECYT, EXEL, ALIM, AMBI, HEB

Blue Horseshoe Stocks: DRIO Update & More

LabStyle Innovations Corp. DRIO

After bringing us cumulative gains of nearly 150% over the course of two spikes since we first picked up on DRIO back on on August 26th, the stock continued to pile on the opportunities yesterday.

We saw it open at a .13 and make a solid 26% intraday run to .164 just prior to the close on nearly twice the one-month average volume. The chart still looks very good, with the RSI just having crossed above oversold status, and the MACD looking bullish as well. As we’ve pointed out below, we caught the bottom on this one perfectly, seeing a steady uptrend since our first tag of DRIO.

Hemispherx BioPharma, Inc. HEB

HEB showed continued resilience in coming up off recent lows after appearing in yesterday morning’s extended watchlist. The stock would trade in a range from .303-.364 on more than 12x the average volume. That was good for a modest yet solid intraday run of 20% and we’ll continue to keep it on our radar moving forward.

Yesterday’s run was fueled in part by the announcement that the company would be working with USAMRIID (U.S. Army Medical Research Institute of Infectious Disease) in studying the effectiveness of two drugs against the ebola virus. >>>Read PR Here

Alkame Holdings, Inc. ALKM

We’re observing significant trading action from ALKM in the pre-market this morning, catching it off one of our routine scans. We noticed the company had a notable distribution agreement in Hawaii this morning which you can >>Read Here. One look at the chart shows that ALKM has recently been recovering from its 52-week lows. This is a stock that we will definitely want to put on our radar as we head into mid-week.

Extended Watchlist:
LUNA, SCOK, CRNT, THLD, CTIC

Blue Horseshoe Stocks: EVLI News, DRIO & More

Everlert, Inc. EVLI

EVLI continued to climb following Friday’s pre-market report; if you recall, following our initial alert of the stock on Thursday, we observed a low of .06, and during Friday’s session it would break our called resistance at .07 to run as high as .09.

Volume returned to normal as well, and with an interesting PR out this morning, we’re anxious to see how EVLI will kick off a fresh trading week. We’ll be looking for support to hold at the previous resistance at .07.

A 50% overnight move is certainly respectable, but according to the report released this morning, we should be on the lookout for even more potential short-term gains.

MONROVIA, Calif., Sept. 8, 2014 (GLOBE NEWSWIRE) — Everlert, Inc. (EVLI) announced today that WEALTHMAKERS.COM, www.wealthmakers.com, a Wall Street research and trading firm providing unbiased statistical stock market predictions to empower investors, securities professionals and public company employees to make precise, predictive and profitable trading decisions, has initiated coverage today on Everlert, Inc. (EVLI). The report highlights the short term bullish pattern that has emerged, the SqueezeTrigger Price of $0.14 and the projected short squeeze valuation of $0.26 per share.

Download the report: http://www.buyins.com/reports/evli9-6-14.pdf

LabStyle Innovations Corp. DRIO

Tracking this play over the past couple of weeks has turned out to provide excellent opportunities for us.

After putting DRIO on our radars on August 26th on the heels of the stock reaching its 52-week low the day prior, we observed a low of .065, and subsequent run to .1367 which culminated last Wednesday, a move of 110%

DRIO consolidated back to a low of .095 on Friday, and bulled its way into the close to touch a high of .127, adding another 34% rip to its resume`, and bringing our cumulative totals to 144% inside of two weeks!

Extended Watchlist:
MSTX, ISNS, HEB, GLUU, PLX, INFN